FDA Orders Cancer Warning For TNF Blockers

Law360, New York (August 4, 2009, 6:37 PM EDT) -- The U.S. Food and Drug Administration has announced that it will require a class of drugs known as tumor necrosis factor alpha blockers to include a stronger warning highlighting the possibility of an increased risk of cancer in children and adolescents.

The heightened warning comes after the FDA conducted an analysis of U.S. reports of cancer in children and adolescents treated with TNF blockers, which work by suppressing the immune system and are approved to treat a variety of conditions, including juvenile rheumatoid arthritis, the inflammatory...
To view the full article, register now.